Transplantation of immuno-protected xenogenic islets of Langerhans by a permselective synthetic membrane represents an intriguing possibility to treat the diabetic disease. In this study, polymeric tubular membrane with a porous wall structure and an internal permselective layer (skin) were fabricated by a combination of spraying and phase-inversion of a thermodynamically unstable solution of a biocompatible PU (90%)-PDMS (10%) blend (Cardiothane™ 51) over a sliding and rotating mandrel. Segments of tubular membranes were capped at both extremities according to the “macroencapsulation” technique.
Reference compounds of different molecular masses were used to evaluate capsules permselectivity characteristics, while glucose, insulin and porcine islets of Langerhans were used to study the diffusion properties. The results of these studies showed the capsules to be impermeable to compounds with a molecular mass higher than approximately 40 000 Da, but permeable to glucose and insulin. Pancreatic islets entrapped within the capsules released, over a 2 h period, insulin proportionally to the glucose concentration in the medium without a significant difference in comparison with the amount of insulin released by non-encapsulated islets. Finally, potential drawbacks deriving from an inaccurate capsules sealing and from the severity of the host tissue reaction versus the structural material are discussed.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
D. W. SCHARP, R. DOWNING, R. C. MERREL and M. GRIEDER, “Isolating the elusive islets”,Diabetes 29 (1980) 19–30.
P. E. LACY, J. M. DAVIE and E. H. FINKE, “Experimental immuno-alteration”,World J. Surg. 8 (1984) 198–203.
P. M. GALLETTI and J. P. ALTMAN, “Extracorporeal treatment of diabetes in man”,Trans. Amer. Soc. Artif. Intern. Org. 30 (1984) 675–677.
G. M. O'SHEA, M. F. A. GOOSEN and A. M. SUN, “Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane”,Biochim. Biophys. Acta 804 (1984) 133–136.
J. J. ALTMAN, D. HOULBERT, P. CALLARD, P. McMILLAN, B. A. SOLOMON, J. ROSEN and P. M. GALLETTI, “Long-term plasma glucose normalization in experimental diabetic rats with macroencapsulated implants of benign human insulinomas”.Diabetes 35 (1986) 625–633.
M. SEGAWA, H. NAKANO, Y. NAKAJIMA H. KANEIRO, Y. MURAO, K. NAKAGAWA and T. SHIRATORI, “Effect of hybrid artificial pancreas on glucose regulation in diabetes”,Transplantation Proc. 19 (1987) 985–988.
D. J. LYMAN, F. J. FAZZIO, H. VOORHES, G. ROBINSON and D. ALBO Jr, “Compliance as a factor affecting the patency of a copolyurethane vascular graft”,J. Biomed. Mater. Res. 12 (1978) 337–345.
R. GUIDON, D. DOMURADO, S. POIGNANT, C. GROSSEHN and J. AWAD, “Stored blood microfiltration evaluation of micro aggregate filter composed of polyurethane foam and nylon wool”,Res. Expr. Med. 171 (1977) 129–139.
S. DURST, J. LESLIE, R. MOORE and K. AMPLATZ, “A comparison of the thrombogenicity of commercially available catheters”,Radiology 133 (1974) 599–600.
M. SZVCHER, D. DEMPSEY and V. L. POIRER, “Surface fissuring of polyurethane based pacemaker leads”,Trans. Soc. Biomater. 7 (1984) 24.
C. B. WISMAN, W. S. PIERCE, J. H. DONACHY, W. E. PAE, J. L. MYERS, and G. A. PROPHET, “A polyurethane trileaflet cardiac valve prosthesis.In vitro andin vivo studies”,Trans. Amer. Soc. Artif. Intern. Org. 28 (1982) 164–168.
J. SNOW, H. HARASAKI, J. KASICK, R. WHALEN, R. KIRALY and Y. NOSE, “Promising results with a new textured surface intrathoracic variable volume device for LVAS”, ibid.27 (1981) 485–489.
J. H. LAWSON, D. B. OLSEN, E. HERSHGOLD, J. KOLFF, K. HADFIELD, and W. J. KOLFF, “A comparison of polyurethane and silastic artificial hearts in 10 long survival experiments in calves”, ibid.21 (1975) 368–373.
G. SOLDANI, G. PANOL, M. GODDARD, H. F. SASKEN and P. M. GALLETTI, “Small-diameter polyurethane vascular prostheses made by a spraying, phase-inversion process”,J. Mater. Sci.: Mater. Med. 3 (1992) 106.
E. NYLAS, and R. S. WARD Jr. “Development of blood-compatible elastomers. V. Surface structure and blood compatibility of Avcothane elastomers”,Polym. Prepr. Amer. Chem. Soc. Div. Polym. Chem. 16 (1975) 681.
E. NYLAS, “Development of blood-compatible elastomers: theory, practice andin vivo performance”, presented at 23rd Annual Conference on Engineering in Medicine and Biology, Washington, D.C., 1970
R. S. WARD Jr and E. NYLAS, “Production of biomedical polymers. I. Silicone/urethane synergy in Avcothane® elastomers”, in “Organometallic polymers”, (Academic Press, Inc., New York, 1972) pp. 219–229.
P. MARCHETTI, L. BENZI, P. CECCHETTI, and R. NAVALESI, “A rapid separation of A14-125 I-insulin from heterogeneous iodination mixture by high-performance liquid chromatography”,J. Nucl. Med. Allied Sci. 28 (1984) 31–35.
P. MARCHETTI, A. ZAPPELLA, R. GIANNARELLI, P. MASIELLO, A. MASONI, E. CASANOVI, V. GATTAI, L. POZZOLINI, A. MARCHETTI and R. NAVALESI “Isolation of islets of Langerhans from the adult pig pancreas.Transplantation Proc. 20 (1988) 707–708.
P. M. GALLETTI, “The concept of bioartificial endocrine organs” in “Organes artificiels hybrides (Hybrid artificial organs)”, edited by C. Baquey and B. Dupuy, Colloque INSERM, Vol. 177, pp. 3–12, 1989.
About this article
Cite this article
Soldani, G., Giusti, P., Marchetti, P. et al. Polyurethane-polydimethylsiloxane (PU-PDMS) tubular membranes for pancreatic islet transplantation. Permselectivity and diffusion studies. J Mater Sci: Mater Med 3, 371–376 (1992). https://doi.org/10.1007/BF00705370
- Molecular Mass
- Pancreatic Islet
- Porous Wall
- Islet Transplantation